# Enfortumab Vedotin (Genetical Recombination) for I.V. Infusion 20mg (パドセブ点滴静注用２０ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291459D2027). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291459D2027
- **Product name (Japanese):** パドセブ点滴静注用２０ｍｇ
- **English title:** Enfortumab Vedotin (Genetical Recombination) for I.V. Infusion 20mg
- **Active ingredient:** エンホルツマブ ベドチン（遺伝子組換え）
- **Active ingredient (INN):** Enfortumab Vedotin (Genetical Recombination)
- **Strength / unit:** ２０ｍｇ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Astellas Pharma (アステラス製薬)
- **NHI price (reference only):** JPY 54059 per ２０ｍｇ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291459D2027
- **JSON:** https://www.nifujipharma.com/api/drugs/4291459D2027

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Enfortumab%20Vedotin%20(Genetical%20Recombination)%20for%20I.V.%20Infusion%2020mg%20(%E3%83%91%E3%83%89%E3%82%BB%E3%83%96%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%E7%94%A8%EF%BC%92%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%204291459D2027#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Enfortumab Vedotin (Genetical Recombination)

- [Enfortumab Vedotin (Genetical Recombination) for I.V. Infusion 30mg (パドセブ点滴静注用３０ｍｇ)](https://www.nifujipharma.com/drugs/4291459D1020) — ３０ｍｇ１瓶, Astellas Pharma